YD Bio Limited Announces FDA INTERACT Meeting for Investigational Dry Eye Biologic
YD Bio Limited has been granted an INTERACT meeting by the FDA to receive early regulatory feedback on its investigational biologic eye drop, YDB-LMSCEV-001, for moderate-to-severe dry eye disease.